ASCB: A CELLebration of Cell Biology Tuesday, January 12, 2016 The last major congress of the year, ASCB is less a platform for launching new products, but one for confirming and consolidating the trends that have emerged over the past 12 months. Three Glaucoma-Related Genes Discovered Tuesday, January 12, 2016 NIH-funded genetics analysis of glaucoma is largest to date.It is All About the Product, Right? Monday, January 11, 2016 Technology Networks met with Waters Corporation at its head office in Milford, MA to better understand the factors they use to drive business success.Pfizer, Adaptive Biotechnologies Collaborate Monday, January 11, 2016 Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next generation sequencing of the adaptive immune system to advance Pfizer’s growing immuno-oncology franchise. Milestone Resource in Wheat Research Now Available for Download Friday, January 08, 2016 Leading on from The Genome Analysis Centre’s (TGAC) previous announcement of their new bread wheat genome assembly, the landmark resource is now publically available to download at the European Bioinformatics Institute’s (EMBL-EBI) Ensembl database for full analysis.NRGene, Illumina Partner Thursday, January 07, 2016 NRGene has signed a co-marketing agreement with Illumina to promote NRGene’s proprietary de novo assembly informatics solution exclusively using Illumina sequencing technology.
Travelling Salesman Uncorks Synthetic Biology Bottleneck Thursday, January 07, 2016 Computer program scrambles genetic codes for production of repetitive DNA and synthetic molecules.Applied Maths Joins the bioMérieux Family Wednesday, January 06, 2016 bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data. Sanofi, Global Genomics Group Partner Wednesday, January 06, 2016 Global Genomics Group ("G3") announced that it has entered into a research collaboration with Sanofi to identify new signaling pathways and targets involved in the etiology of coronary artery disease.